Breast cancer is categorized into three major subtypes based on the presence or absence of molecular markers for estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor 2 (ERBB2, formerly HER2/neu). This evidence concerns the gene ESR1 and breast carcinoma.